$GWPH Recent Headlines Jim Cramer's Top Stock
Post# of 102083
Jim Cramer's Top Stock Picks: MON GIS PPG EOG UNP GWPH STZ 6:00 a.m. Today - TheStreet.com
'Fast Money' Recap: Muddling Along to Another All-Time High 5:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:18 p.m. June 20, 2014 - TheStreet.com
Jim Cramer's Stop Trading: GW Pharmaceuticals Is 'A Winner' 11:02 a.m. June 19, 2014 - TheStreet.com
Cramer's Mad Money - Expensive Skepticism (6/18/14) 6:39 a.m. June 19, 2014 - Seeking Alpha
Jim Cramer's Stop Trading: Buy GW Pharmaceuticals, Not ConAgra Foods 11:42 a.m. June 18, 2014 - TheStreet.com
GW Pharma To Raise $86 Million In Offering; Shares Down Off All-Time High 9:09 a.m. June 18, 2014 - benzinga.com
GW Pharmaceuticals (GWPH) Soars: Stock Adds 16.2% in Session - Tale of the Tape 8:30 a.m. June 18, 2014 - Zacks.com
GW Pharma raises capital and certain shareholders cash out 7:24 a.m. June 18, 2014 - Seeking Alpha
'Fast Money' Recap: Waiting on the Fed 5:00 a.m. June 18, 2014 - TheStreet.com
Why GW Pharmaceuticals (GWPH) Stock Hit a One-Year High Today 1:04 p.m. June 17, 2014 - TheStreet.com
Jim Cramer's Stop Trading: GW Pharmaceuticals Is for Real 11:19 a.m. June 17, 2014 - TheStreet.com
GW Pharma Up On Positive Data For Epilepsy Drug 10:59 a.m. June 17, 2014 - Investors Business Daily
Encouraging preliminary data for Epidiolex 8:15 a.m. June 17, 2014 - Seeking Alpha
How the U.S. Government Makes Money on Cannabis 11:30 a.m. June 13, 2014 - TheStreet.com
3 Reasons to be Bullish on Marijuana 7:48 a.m. June 12, 2014 - Wall St. Cheat Sheet
GW Pharma Gets Fast-Track Designation for Epidiolex - Analyst Blog 5:40 p.m. June 9, 2014 - Zacks.com
GW Pharmaceuticals (GWPH) Jumps: Stock Rises 6.2% - Tale of the Tape 9:46 a.m. June 9, 2014 - Zacks.com
Cramer's Lightning Round - Amazon Has Lost Its Cult Status (6/6/14) 6:55 a.m. June 8, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Avoid Cliffs Natural Resources 6:00 a.m. June 7, 2014 - TheStreet.com
Conference Call Schedules, Acquisitions, and Public Offerings - Analyst Notes on Johnson & Johnson, Merck, GW, Endocyte and AVEO 6:10 a.m. June 20, 2014 - PR Newswire - PRF
GW Pharmaceuticals plc Announces Pricing of U.S. Public Offering of ADSs Totalling Approximately $148 Million on NASDAQ Global Market 7:06 p.m. June 18, 2014 - GlobeNewswire
Cannabis Therapy Pursues IP Strategy in Cannabis Industry 9:29 a.m. June 18, 2014 - ACCESSWIRE
GW Pharmaceuticals Announces Proposed Public Offering of ADSs 4:07 p.m. June 17, 2014 - GlobeNewswire
CannabisFN Weekly: Stocks Tread Water amid Regulatory Gains 2:00 p.m. June 17, 2014 - ACCESSWIRE
Intelligent Highway Solutions Finds Itself in the Right Place at the Right Time 9:48 a.m. June 17, 2014 - ACCESSWIRE
Novus (NDEV) Aims to Fill Key Void in Cannabis Industry 8:04 a.m. June 16, 2014 - ACCESSWIRE
Equity Coverage on Pharma Industry -- Research on AbbVie, AcelRx Pharma, Bristol-Myers Squibb, and GW Pharma 7:10 a.m. June 13, 2014 - PR Newswire - PRF
FDA Drug Approvals, Dividends, Fast Track Designation, Event Sponsorship, and Expansion of Role - Analyst Notes on Biogen Idec, UnitedHealth Group, GW Pharmaceuticals, Questcor and Cigna 5:10 a.m. June 11, 2014 - PR Newswire - PRF
Cannabis Therapy Targets Low-Hanging Fruit with Experienced Team 9:38 a.m. June 10, 2014 - ACCESSWIRE
CannabisFN Weekly: Canadian MMPRs Draw Closer to Commercialization 12:06 p.m. June 9, 2014 - ACCESSWIRE
GW Pharmaceuticals Announces Epidiolex(R) Receives Fast Track Designation From FDA for the Treatment of Dravet Syndrome 1:59 a.m. June 6, 2014 - GlobeNewswire
Cannabis Therapy Corp: Near-term Path to Market with Nutraceuticals 9:33 a.m. June 3, 2014 - ACCESSWIRE
Development of Cannabinoid-Based Therapies Becoming More Prevalent by Leaps and Bounds - CBIS Forges Ahead with Cannabis-Based Cancer Treatments 9:00 a.m. June 2, 2014 - PR Newswire - PRF
A Diversified Bet on the Marijuana Sector 9:57 a.m. May 29, 2014 - ACCESSWIRE
CannabisFN Weekly: Water Rights Could Become an Issue for Cannabis Growers 9:01 a.m. May 27, 2014 - ACCESSWIRE
Clinical Studies for Cannabis Based Drug Development Targets Multitude of Medical Treatments - CBIS Issues CBN Patent and R&D Guidance 11:30 a.m. May 22, 2014 - PR Newswire - PRF
NTRR Preps Vapor Pen for Summer Release Into Booming Marketplace 5:00 a.m. May 22, 2014 - BusinessWire - BZX
Abattis Bioceuticals' Full-Spectrum Seed-to-Sale Aggregator Model Poised to Capture Upside in Marijuana Industry 10:21 a.m. May 21, 2014 - ACCESSWIRE
Cannabis Therapy Secures Lease & Crop Management Services 9:05 a.m. May 21, 2014 - ACCESSWIRE